Anti-tumor and antiviral activities of various aroma samples, including cinnamic acid, β-caryophyllene, caryophyllene oxide, nerolidol (synthetic and natural samples), trans,trans-farnesol, farnesol (isomeric mixture), longifolene, geranic acid and a farnesol-rich ylang-fraction were investigated using HeLa and Jurkat cell lines.
effects of established drugs against oncogenic viruses are quite common during therapy, and far less toxic compounds are required [2] . Although anticancer [3] and antiviral properties [4] of aromatic compounds have already been described in the literature, little is known about the possible action of essential oils and their main aromatic components on oncogenic viruses.
Polyomaviruses have been found to be viral agents for oncogenesis and produce a wide range of pathological lesions [5] . The human polyomaviruses (JCV and BK) are ubiquitous and infections often remain asymptomatic, but can cause severe diseases in immunocompromized individuals, especially as a result of AIDS, advanced malignancy or organ transplantation [6] . Modern treatment of diseases caused by human polyomaviruses has quite low effectiveness and often induces complications. Currently, only few scientific data about possible activity of natural compounds against human polyomaviruses are available. Therefore, further research exploring new possible strategies in the treatment of human polyomavirus associated diseases is required.
In the present study, anti-tumor and antiviral potential of various aromatic samples, namely cinnamic acid, β-caryophyllene, caryophyllene oxide, nerolidol (synthetic and natural), trans,trans-farnesol, Farnesol (isomer mixture) < 10 < 10 CC 50 : sample concentration required to reduce the number of cells to 50%; ED 50 : effective dose of the sample required to achieve 50% of cytotoxicity for cells farnesol (mixture of different isomers), longifolene geranic acid and a farnesol-rich ylang-fraction, were investigated on HeLa cells. Jurkat cells were also included in the analyses to account for the possibility of cell-type specific activity of the samples investigated.
As presented in Table 1 , effectiveness of these aroma samples on the viability of HeLa cells ranged from high (nerolidol synthetic, CC 50 1.5 ± 0.7 µM) to no activity (cinnamic acid and geranic acid, both CC 50 and ED 50 > 100 µM). A reduction of HeLa cells, growing as a monolayer, to 50% was observed after applying trans,trans-farnesol and nerolidol (natural and synthetic) at concentrations (CC 50 ) less than 5 μM. Moreover, the CC 50 of synthetic nerolidol in HeLa cells was almost ten times less than the effective dose required to achieve 50% cytotoxicity of the cells (ED 50 ). Farnesol (isomer mixture) and β-caryophyllene demonstrated inhibitory effects on the growth of HeLa cells at concentrations (CC 50 ) less than 15 μM. Since nerolidol synthetic and natural have been demonstrated to have a high activity, additional tests were carried out to determine the precise CC 50 values of these samples (also repeated for samples of trans,trans-farnesol and farnesol mixture). Cinnamic-and geranic acid did not show any activity against either cell line at concentrations less than 100 μM.
To account for the cell type-specific effect of the samples the test was also performed on Jurkat cells. Synthetic nerolidol reduced the number of Jurkat cells, growing in suspension, to 50% at 4.6 ± 2.4 μM (CC 50 ). Nevertheless, the difference between CC 50 and ED 50 values for the synthetic nerolidol in Jurkat cells was not statistically significant (data not shown).
In addition, inhibition of mouse polyomavirus production in 3T6 cells was observed for synthetic nerolidol at CC 50 3.2 ± 1.5 μM and natural nerolidol at CC 50 1.2 ± 0.4 μM. While the effective concentration (CC 50 ) of natural nerolidol against mouse polyomavirus appeared to be more than ten times lower compared with the cytotoxic dose (ED 50 ), the synthetic nerolidol showed a CC 50 three times lower compared with the ED 50 (ED 50 11 ± 1.8 μM and 10.6 ± 3 μM, respectively). All other aroma samples, except trans,trans-farnesol, and farnesol (isomer mixture), which were not tested, did not show any significant antiviral activity in concentrations less than ED 50 (data not shown).
We have obtained, for the first time, a remarkable reducing effect of natural and synthetic nerolidol and trans,trans-farnesol on the viability of tumor cells. Furthermore, antiviral activity of natural and synthetic nerolidol against mouse polyomavirus could be observed. Similarity in the activity against tumor cells between nerolidol and farnesol could be due to their similar chemical structure.
It is obvious that mouse polyomavirus infection is absolutely dependent on host cell transcription and replication machinery [7] . In view of this, our findings about general effects of nerolidol on the viability of tumor cells and mouse polyomavirus infection provide the basis for further investigations about the mechanisms responsible for the activity of nerolidol.
Future research will focus on correlations between different isomer compositions of nerolidol and their activity against tumor cells.
Experimental

Aroma compounds and essential oils:
Cinnamic acid, β-caryophyllene, caryophyllene oxide, trans,trans-farnesol, and geranic acid were purchased from Sigma-Aldrich (Wien, Austria). Farnesol (isomeric mixture containing cis,cis-farnesol 1.3%, cis,trans and trans-cis farnesol 48.5%, trans,trans farnesol 50.2%), farnesol-rich ylang-fraction (containing linalylacetate 0.1%, prenylbenzoate and methylisoeugenol 2.6%, α-farnesene 58.4%, λ-cadinene 4.9%, δ-cadinene 23.1%, cadina-1.4-diene 2.4%, α-cadinene 3.4%), natural nerolidol (> 99% trans-farnesol), synthetic nerolidol (contains cisnerolidol 40.7%, trans-nerolidol 58.3%, cisdihydronerolidol 0.4% and trans-dihydronerolidol Antiviral and anticancer properties of aroma samples Natural Product Communications Vol. 3 (7) 2008 1087 0.6%) and longifolene were purchased from Kurt Kitzing Co. (Wallerstein, Germany). Each aroma compound was dissolved in dimethylsulfoxide (DMSO) and subsequently diluted in the medium. To avoid DMSO toxicity or interference, the maximum concentration of DMSO in the test medium was kept to 0.5%.
Virus and cells:
HeLa (human cervix carcinoma) and Jurkat E6.1 (human leukaemic T cell lymphoblast, derived from a patient with acute lymphoblastic leukemia) cell lines were grown in RPMI 1640 medium (SIGMA), supplemented with 2 mM l-glutamine and 10% FBS. Mouse polyomavirus was propagated in 3T6 cells (Swiss albino mouse fibroblasts) using Dulbecco's modified Eagle's medium (DMEM; Sigma) supplemented with 4 mM l-glutamine and 10% FBS. Cells were grown at 37°C in a 5% CO 2 -air humidified incubator. For virus infections, mouse polyomavirus (MPyV) strain A2 was used at the multiplicity of infection (MOI) 5 plaque-forming units per cell (PFU/cell).
Virus infection and isolation:
3T6 cells were washed with DMEM and incubated with virus inoculum for 1 h at 37ºC. After that, DMEM supplemented with 10% FBS and containing compounds to be analyzed was added. MPyV was isolated from the cells according to the modified standard protocol [8] . Briefly, cells after repetitive freezing cycles were centrifuged for 40 min at 4300 rpm at 4ºC and the supernatant was collected for further use. The sediment was resuspended in 10 mM Tris HCl (pH 7.4), homogenized (Potter homogenizer) and centrifuged for 40 min at 4300 rpm at 4ºC. The supernatant was mixed with the previous one and centrifuged through 10% sucrose in an ultracentrifuge (Beckman) for 3 h (35,000 RPM, 4ºC). The sediment was resuspended and used for virus titration.
Virus titration:
The titer of virus was estimated by immunofluorescence microscopy. Briefly, 3T6 cells grown on coverslips were infected following the procedure as described above. Cells were fixed for 24 h post infection with 4% paraformaldehyde in PBS (15 min), and permeabilized with 0.5% Triton X-100 in PBS (5 min). Immunostaining with primary and secondary antibodies was carried out with monoclonal rat anti-PyV Large T antigen (prepared in our laboratory) and goat anti-rat conjugated with Alexa Fluor-488 dye, respectively.
Cellular toxicity:
Cellular toxicity of natural and synthetic aroma compounds was tested using the CytoTox-96® Assay according to the standard manufacturer's protocol. The EC 50 values were calculated by regression analysis of the dose response curves generated from the data.
